Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tse Hui Lim

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Fluorescence In Situ Hybridization on Tissue SectionsAlvin S T Lim, Tse Hui Lim
Annals of Diagnostic Pathology|March 21, 2022
Impact of the updated 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) gene testing in invasive breast cancers: A single center studyTse Hui Lim, Alvin Soon Tiong Lim, Sim Leng Tien, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2016
Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast CancerTse Hui Lim, Alvin Soon Tiong Lim, Aye Aye Thike, et al.
Cancer Genetics and Cytogenetics|December 11, 2007
Loss of the extra chromosome 21 in a patient with Down syndrome and myelodysplasiaDaryl Tan, Lai Ching Lau, Li Min Teng, et al.
Journal of Andrology|September 8, 2006
Correlation between semen parameters and the Hamster Egg Penetration Test (HEPT) among fertile and subfertile men in SingaporeLee Mee Ho, Alvin Soon Tiong Lim, Tse Hui Lim, et al.
Cancer Genetics|December 20, 2020
Implementation of cytogenomic microarray with plasma cell enrichment enables better abnormality detection and risk stratification in patients with plasma cell neoplasia than conventional cytogenetics and fluorescence in situ hybridizationChuanfei Chen, Alvin Soon Tiong Lim, Lai Ching Lau, et al.
Cancer Genetics and Cytogenetics|May 19, 2005
Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemiaGeok Yee Lee, Sivaswaren Christina, Sim Leng Tien, et al.
Virchows Archiv : an International Journal of Pathology|June 6, 2021
Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 casesTimothy Kwang Yong Tay, Nadiah Binte Sukma, Tse Hui Lim, et al.
International Journal of Hematology|October 11, 2014
CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL)Fiona Pui San Liaw, Lai Ching Lau, Alvin Soon Tiong Lim, et al.
Journal of Clinical Pathology|December 7, 2010
HER2/neu revisited: quality and interpretive issuesSyed Salahuddin Ahmed, Jabed Iqbal, Aye Aye Thike, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Fluorescence In Situ Hybridization on Tissue SectionsAlvin S T Lim, Tse Hui Lim
Annals of Diagnostic Pathology|March 21, 2022
Impact of the updated 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) gene testing in invasive breast cancers: A single center studyTse Hui Lim, Alvin Soon Tiong Lim, Sim Leng Tien, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2016
Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast CancerTse Hui Lim, Alvin Soon Tiong Lim, Aye Aye Thike, et al.
Cancer Genetics and Cytogenetics|December 11, 2007
Loss of the extra chromosome 21 in a patient with Down syndrome and myelodysplasiaDaryl Tan, Lai Ching Lau, Li Min Teng, et al.
Journal of Andrology|September 8, 2006
Correlation between semen parameters and the Hamster Egg Penetration Test (HEPT) among fertile and subfertile men in SingaporeLee Mee Ho, Alvin Soon Tiong Lim, Tse Hui Lim, et al.
Cancer Genetics|December 20, 2020
Implementation of cytogenomic microarray with plasma cell enrichment enables better abnormality detection and risk stratification in patients with plasma cell neoplasia than conventional cytogenetics and fluorescence in situ hybridizationChuanfei Chen, Alvin Soon Tiong Lim, Lai Ching Lau, et al.
Cancer Genetics and Cytogenetics|May 19, 2005
Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemiaGeok Yee Lee, Sivaswaren Christina, Sim Leng Tien, et al.
Virchows Archiv : an International Journal of Pathology|June 6, 2021
Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 casesTimothy Kwang Yong Tay, Nadiah Binte Sukma, Tse Hui Lim, et al.
International Journal of Hematology|October 11, 2014
CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL)Fiona Pui San Liaw, Lai Ching Lau, Alvin Soon Tiong Lim, et al.
Journal of Clinical Pathology|December 7, 2010
HER2/neu revisited: quality and interpretive issuesSyed Salahuddin Ahmed, Jabed Iqbal, Aye Aye Thike, et al.
Pageof 4